Table 2—

Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) of lung cancer among asthma patients according to selected characteristics of the cohort

MalesFemalesTotal
ObsSIR95% CIObsSIR95% CIObsSIR95% CI
Total4921.511.38–1.652211.781.55–2.037131.581.47–1.70
Duration of follow-up
 1–4 yrs2741.991.76–2.241102.321.91–2.803842.071.87–2.29
 5–9 yrs1301.311.10–1.56611.621.24–2.081911.401.20–1.61
 ≥10 yrs880.990.79–1.22501.270.94–1.681381.080.90–1.27
 Test for linear trend#<0.01<0.01<0.01
Calendar year at entry
 1965–19741171.150.95–1.38411.290.93–1.751581.181.01–1.38
 1975–19842261.591.39–1.81831.541.23–1.913091.571.40–1.76
 1985–19941491.811.53–2.13972.502.03–3.052462.031.79–2.30
Test for linear trend#<0.01<0.01<0.01
Age at entry
 20–44130.870.46–1.49161.270.72–2.06291.050.71–1.51
 45–591221.190.99–1.43671.531.19–1.941891.301.12–1.49
 ≥603571.711.54–1.901382.031.70–2.394951.791.63–1.95
 Test for linear trend#<0.010.02<0.01
Other diagnoses at index hospitalization
 Asthma as only diagnosis1891.241.07–1.43891.431.15–1.762781.291.14–1.45
 Asthma as main diagnosis1281.621.35–1.93531.761.32–2.301811.661.43–1.92
 Asthma as secondary diagnosis1751.861.59–2.15792.471.95–3.082542.011.77–2.27
Dept of index hospitalization
 Internal/respiratory medicine3921.411.27–1.561771.671.43–1.935691.481.36–1.61
 Other1002.091.70–2.55442.421.76–3.251442.181.84–2.57
Number of hospitalizations during first year of follow-up
 13481.661.49–1.851491.811.53–2.124971.701.56–1.86
 2–31101.301.06–1.56551.701.28–2.211661.411.21–1.65
 ≥4331.040.72–1.46171.771.03–2.83501.210.90–1.59
 Test for linear trend#<0.010.78<0.01
Presence of emphysema
 No4861.511.38–1.652191.781.55–2.037051.591.47–1.71
 Yes61.220.45–2.6621.650.20–5.9581.310.56–2.58
Presence of chronic bronchitis
 No3011.201.07–1.341501.421.20–1.674511.271.15–1.39
 Yes1912.542.19–2.93713.762.93–4.742622.792.46–3.15
Histological type of lung cancer
 Squamous cell carcinoma2331.831.61–2.09813.222.56–4.003142.061.84–2.30
 Adenocarcinoma661.110.86–1.41430.990.71–1.331091.060.87–1.27
 Small cell carcinoma*171.901.11–3.05153.181.78–5.25322.341.60–3.31
  • Obs: observed

  • #: p-value

  • *: follow-up 1987–1994